Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments.

Yap DYH, Chan TM.

Int J Mol Sci. 2019 Dec 10;20(24). pii: E6231. doi: 10.3390/ijms20246231. Review.

2.

Low-dose corticosteroid and mycophenolate for primary treatment of minimal change disease.

Ma MKM, Yap DYH, Li CL, Mok MMY, Chan GCW, Kwan LPY, Lai KN, Tang SCW.

QJM. 2019 Nov 26. pii: hcz297. doi: 10.1093/qjmed/hcz297. [Epub ahead of print]

PMID:
31769845
3.

Effect of mycophenolate and rapamycin on renal fibrosis in lupus nephritis.

Zhang C, Chan CCY, Cheung KF, Chau MKM, Yap DYH, Ma MKM, Chan KW, Yung S, Chan TM.

Clin Sci (Lond). 2019 Aug 5;133(15):1721-1744. doi: 10.1042/CS20190536. Print 2019 Aug 15.

PMID:
31358596
4.

Long-term data on entecavir treatment for treatment-naive or lamivudine-resistant chronic hepatitis B infection in kidney transplant recipients.

Yap DYH, Tang C, Fung JYY, Seto WK, Ma MKM, Choy BY, Chan TM.

Transpl Infect Dis. 2019 Oct;21(5):e13143. doi: 10.1111/tid.13143. Epub 2019 Jul 18.

PMID:
31282041
5.

Clinical Outcomes and Clinico-pathological Correlations in Lupus Nephritis with Kidney Biopsy Showing Thrombotic Microangiopathy.

Li C, Yap DYH, Chan G, Wen YB, Li H, Tang C, Li XM, Li XW, Chan TM.

J Rheumatol. 2019 Nov;46(11):1478-1484. doi: 10.3899/jrheum.180773. Epub 2019 Mar 15.

PMID:
30877215
6.

A young Chinese man with nephrotic syndrome due to lipoprotein glomerulopathy.

Lui DTW, Lee ACH, Yap DYH, Chan GSW, Tan KCB.

J Clin Lipidol. 2019 Mar - Apr;13(2):251-253. doi: 10.1016/j.jacl.2018.12.004. Epub 2018 Dec 19.

PMID:
30685233
7.

Longterm Data on Sirolimus Treatment in Patients with Lupus Nephritis.

Yap DYH, Tang C, Chan GCW, Kwan LPY, Ma MKM, Mok MMY, Chan TM.

J Rheumatol. 2018 Dec;45(12):1663-1670. doi: 10.3899/jrheum.180507. Epub 2018 Oct 1.

PMID:
30275264
8.

Pharmacokinetics and pharmacogenomics of mycophenolic acid and its clinical correlations in maintenance immunosuppression for lupus nephritis.

Yap DYH, Tam CH, Yung S, Wong S, Tang CSO, Mok TMY, Yuen CKY, Ma MKM, Lau CS, Chan TM.

Nephrol Dial Transplant. 2018 Sep 11. doi: 10.1093/ndt/gfy284. [Epub ahead of print]

PMID:
30215770
9.

A Longitudinal Study on the Prevalence and Risk Factors for Depression and Anxiety, Quality of Life, and Clinical Outcomes in Incident Peritoneal Dialysis Patients.

Mok MMY, Liu CKM, Lam MF, Kwan LPY, Chan GCW, Ma MKM, Yap DYH, Chiu F, Choy CBY, Tang SCW, Chan TM.

Perit Dial Int. 2019 Jan-Feb;39(1):74-82. doi: 10.3747/pdi.2017.00168. Epub 2018 Jul 10.

PMID:
29991560
10.

Palliative Care Consultation in Advanced Chronic Kidney Disease with Pain.

Chan KY, Yap DYH, Yip T, Sham MK, Lui SL, Chan TM.

J Palliat Med. 2018 Jun;21(6):809-814. doi: 10.1089/jpm.2017.0505. Epub 2018 Mar 12.

PMID:
29596025
11.

Preemptive immunosuppressive treatment for asymptomatic serological reactivation may reduce renal flares in patients with lupus nephritis: a cohort study.

Yap DYH, Kwan LPY, Ma MKM, Mok MMY, Chan GCW, Chan TM.

Nephrol Dial Transplant. 2019 Mar 1;34(3):467-473. doi: 10.1093/ndt/gfy024.

PMID:
29509932
12.

Longterm Data on Disease Flares in Patients with Proliferative Lupus Nephritis in Recent Years.

Yap DYH, Tang C, Ma MKM, Mok MMY, Chan GCW, Kwan LPY, Chan TM.

J Rheumatol. 2017 Sep;44(9):1375-1383. doi: 10.3899/jrheum.170226. Epub 2017 Jul 1.

PMID:
28668803
13.

Mycobacterium chlorophenolicum: An uncommon cause of peritonitis in a peritoneal dialysis patient.

Chan GCW, Mok MMY, Hung DLL, Chan JFW, Kwan LPY, Ma MKM, Yap DYH, Tang SCW.

Nephrology (Carlton). 2017 Jun;22(6):498-499. doi: 10.1111/nep.12820. No abstract available.

PMID:
28429521
14.

Annexin II-binding immunoglobulins in patients with lupus nephritis and their correlation with disease manifestations.

Cheung KF, Yung S, Chau MK, Yap DY, Chan KW, Lee CK, Tang CS, Chan TM.

Clin Sci (Lond). 2017 Apr 25;131(8):653-671. doi: 10.1042/CS20160732. Epub 2017 Feb 9.

PMID:
28183811
15.

A Rare Case of Famotidine-Induced Delirium in a Peritoneal Dialysis Patient.

Chan GC, Lee KM, Kwan LP, Mok MM, Ma MK, Yap DY, Tang SC.

Perit Dial Int. 2017 1-2;37(1):118-120. doi: 10.3747/pdi.2016.00145. Review.

PMID:
28153970
16.

Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis.

Yap DY, Seto WK, Fung J, Chok SH, Chan SC, Chan GC, Yuen MF, Chan TM.

Dig Liver Dis. 2017 Feb;49(2):202-206. doi: 10.1016/j.dld.2016.11.001. Epub 2016 Nov 10.

PMID:
27876501
17.

Binding of anti-dsDNA antibodies to proximal tubular epithelial cells contributes to renal tubulointerstitial inflammation.

Yung S, Ng CY, Au KY, Cheung KF, Zhang Q, Zhang C, Yap DY, Chau MK, Chan TM.

Clin Sci (Lond). 2017 Jan 1;131(1):49-67. Epub 2016 Oct 25.

PMID:
27780843
18.

Epidemiology and Clinical Characteristics of Acinetobacter Peritoneal Dialysis-Related Peritonitis in Hong Kong-With a Perspective on Multi-Drug and Carbapenem Resistance.

Li PH, Cheng VC, Yip T, Yap DY, Lui SL, Lo WK.

Perit Dial Int. 2017 Mar-Apr;37(2):177-182. doi: 10.3747/pdi.2016.00123. Epub 2016 Sep 28.

PMID:
27680764
19.

Lupus Nephritis in Asia: Clinical Features and Management.

Yap DY, Chan TM.

Kidney Dis (Basel). 2015 Sep;1(2):100-9. doi: 10.1159/000430458. Epub 2015 Aug 5. Review.

20.

Excessive watermelon consumption causing hyperkalaemia and increased symptom burden of an end stage renal disease patient.

Chan KY, Yap DY, Li CW, Cheng HW, Au HY.

Nephrology (Carlton). 2016 Aug;21(8):721. doi: 10.1111/nep.12655. No abstract available.

PMID:
27436619

Supplemental Content

Loading ...
Support Center